GlassScriptPhysician profile
Srinivas Rajendran
NPI 1497050132
$3,562.24
in general payments reported to CMS, 2019-2025
20 companies · $541 in 2025
The $541 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $100 · 2021: $547 · 2022: $610 · 2023: $665 · 2024: $706 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,445.77 | 2019-2025 | Jot Dx, Aveir, Merlin@Home |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $663.96 | 2019-2025 | Lifevest |
| Abiomed | $307.28 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $249.71 | 2019-2024 | Farxiga |
| Shockwave Medical, INC | $170.76 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.92 | 2020-2025 | Jardiance |
| Biotronik INC. | $89.29 | 2021-2023 | Biomonitor |
| Pfizer INC. | $74.97 | 2021-2022 | |
| Bolton Medical INC | $69.32 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $60.73 | 2019-2023 | Eliquis |
| Cook Medical LLC | $58.74 | 2022-2024 | Zilver Ptx, Rosen |
| Boston Scientific Corporation | $51.32 | 2020-2025 | Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $47.48 | 2023-2024 | Linq II, Reveal Linq, Mycarelink |
| Merck Sharp & Dohme LLC | $44.00 | 2023 | Verquvo |
| Philips North America LLC | $34.12 | 2024 | (Ck7) Extended Holter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.40 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2021 | |
| Amgen INC. | $15.66 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.62 | 2023 | Onpattro |
| Medicomp INC | $13.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Rajendran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.